These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 10454462

  • 1. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein.
    Cohen ML, Schenck K.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):935-9. PubMed ID: 10454462
    [Abstract] [Full Text] [Related]

  • 2. Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha).
    Cohen ML, Schenck K.
    Br J Pharmacol; 2000 Oct; 131(3):562-8. PubMed ID: 11015308
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 2. Evidence of involvement of 5-HT1B receptors using functional studies.
    Rogines-Velo MP, Pelorosso FG, Zold CL, Brodsky PT, Rothlin RP.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):596-604. PubMed ID: 12444502
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW, Pauwels PJ, Perez M, Halazy S, Le Grand B, Verscheure Y, Valentin JP, Palmier C, Wurch T, Chopin P, Marien M, Kleven MS, Koek W, Assie MB, Carilla-Durand E, Tarayre JP, Colpaert FC.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [Abstract] [Full Text] [Related]

  • 11. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP, Bonnafous R, John GW.
    Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonists.
    Halazy S, Perez M, Fourrier C, Pallard I, Pauwels PJ, Palmier C, John GW, Valentin JP, Bonnafous R, Martinez J.
    J Med Chem; 1996 Dec 06; 39(25):4920-7. PubMed ID: 8960551
    [Abstract] [Full Text] [Related]

  • 14. Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles.
    Elhusseiny A, Hamel E.
    Br J Pharmacol; 2001 Jan 06; 132(1):55-62. PubMed ID: 11156561
    [Abstract] [Full Text] [Related]

  • 15. In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist.
    Ahlgren C, Eriksson A, Tellefors P, Ross SB, Stenfors C, Malmberg A.
    Eur J Pharmacol; 2004 Sep 19; 499(1-2):67-75. PubMed ID: 15363952
    [Abstract] [Full Text] [Related]

  • 16. The GR127935-sensitive 5-HT(1) receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT(1B), but not to the 5-HT(1D) or 5-ht(1F), receptor subtype.
    Centurión D, Sánchez-López A, De Vries P, Saxena PR, Villalón CM.
    Br J Pharmacol; 2001 Mar 19; 132(5):991-8. PubMed ID: 11226129
    [Abstract] [Full Text] [Related]

  • 17. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
    Kodama A, Komori K, Kajikuri J, Itoh T.
    J Vasc Surg; 2009 Sep 19; 50(3):617-25. PubMed ID: 19700096
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous measurement of [3H]noradrenaline release and neurogenic contraction under identical conditions, to determine the prejunctional inhibitory effects of SKF 99101H and BRL 56905 in dog saphenous vein.
    Medhurst AD, Brown AM, Kaumann AJ, Parsons AA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr 19; 355(4):475-82. PubMed ID: 9109364
    [Abstract] [Full Text] [Related]

  • 19. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat.
    Villalón CM, Heiligers JP, Centurión D, De Vries P, Saxena PR.
    Br J Pharmacol; 1997 Jul 19; 121(6):1187-95. PubMed ID: 9249256
    [Abstract] [Full Text] [Related]

  • 20. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR, Robertson AD, MacLennan SJ, Prentice DJ, Barrett VJ, Buckingham J, Honey AC, Giles H, Moncada S.
    Br J Pharmacol; 1997 May 19; 121(2):157-64. PubMed ID: 9154322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.